Apex Attending Psychedelic Therapeutics and Drug Development Conference
Are you attending the 2nd Annual Psychedelic Therapeutics and Drug Development Conference in Washington, DC on May 23-24, 2022? Apex Innovative Sciences'...
Are you attending the 2nd Annual Psychedelic Therapeutics and Drug Development Conference in Washington, DC on May 23-24, 2022? Apex Innovative Sciences'...
Elan Cohen, Ph.D., Principal Investigator at HRI, will be presenting "Enhancing Participant Retention: Lessons Gained From Attention-Deficit/ Hyperactivity...
ASCP 2022 starts in just twenty-nine days! Have you scheduled time with Apex Innovative Sciences to talk about your upcoming clinical trials? Our Senior...
Are you heading to SIRS 2022 in Florence, Italy 6-10 April, 2022? Apex Innovative Sciences is pleased to share that Dr. Elan Cohen, Ph.D., Principal Investigator...
Looking for a list of this year's prominent neuroscience conferences? Apex’s annual eCard has you covered. We are excited to connect with you at many...
Thank you to the readers of Metro Philadelphia for voting HRI the Best Medical Research Facility in Philadelphia! As a company that strives to demonstrate...
Apex Principal Investigators, Drs. Howard Hassman and David Walling at Hassman Research Institute (HRI) and Collaborative Neuroscience Research (CNS),...
Apex’s partner for driving simulation studies, Cognitive Research Corporation, authored an article (https://doi.org/10.1111/cts.13145) about a clinical...
2022 Apex Innovative Sciences
| Privacy | Accessibility